None

Oncofertility at Gynatal Clinic helps women and men preserve reproductive cells before chemotherapy, radiotherapy or surgery that may affect fertility. Priority assessment and urgent protocols allow egg freezing to be completed in many cases within approximately 10–14 days, while sperm can often be frozen in a single visit. Care is coordinated with the oncology team so that fertility preservation fits safely within the cancer treatment schedule. 

Why Fertility Preservation Matters

Cancer treatment is the immediate priority, but some therapies may permanently damage the ovaries, oocytes, sperm-producing cells or reproductive organs. Discussing fertility early may protect the possibility of having a biological child in the future. 

At Gynatal, oncology patients receive priority scheduling. The fertility specialist reviews the diagnosis, planned treatment and available time, and coordinates the proposed procedure with the patient’s oncologist. 

Who should consider an urgent consultation? 

Fertility preservation may be recommended before treatments associated with a risk of infertility: 

  • Chemotherapy or Radiotherapy: particularly treatment affecting the pelvis, reproductive organs or the whole body. 

  • Oncological Surgery: procedures involving the ovaries, uterus, testicles or other reproductive structures. 

  • Stem Cell or Bone Marrow Transplantation: treatments that may severely affect ovarian or testicular function. 

  • Other Gonadotoxic Treatments: long-term or intensive therapies that may reduce future fertility. 

Fertility Preservation Options at Gynatal

Oocyte Cryopreservation 

Mature oocytes are collected after ovarian stimulation and preserved by vitrification. A random-start protocol may allow stimulation to begin without waiting for the next menstrual cycle. The process can often be completed within approximately 10–14 days, depending on the patient’s response and oncology schedule. 

Embryo Cryopreservation 

Retrieved oocytes may be fertilised with partner or donor sperm and the resulting embryos frozen for future use. The medical, practical and legal implications are explained before the patient makes a decision. 

Sperm Cryopreservation 

Sperm freezing is usually the fastest method of male fertility preservation. A sample can often be analysed, processed and frozen in one day before the first oncology treatment. When time permits, more than one sample may be recommended. 

Ovarian Tissue Cryopreservation 

This specialised option may be considered for selected patients who cannot undergo ovarian stimulation, including some children. Availability and any referral to a specialist centre must be assessed individually. 

The Gynatal Process: Fast, Clear and Coordinated 

Our team simplifies the process so that essential decisions can be made without unnecessary delay: 
None

Priority Consultation

Contact Gynatal as soon as possible and provide the planned date of your cancer treatment, if known. 

None

Medical Assessment

The specialist reviews your oncology plan, reproductive health and the time available. Women may need an ultrasound and ovarian reserve tests; men usually undergo semen analysis. 

None

Coordination with Your Oncologist

The recommended method and timing are confirmed with the oncology team. Cancer treatment will not be delayed without medical agreement. 

None

Collection and Cryopreservation

Oocytes are retrieved following stimulation, while sperm is collected directly or, in selected cases, obtained surgically. Suitable cells are processed and frozen in the laboratory. 

None

Secure Storage and Future Planning

Stored oocytes, embryos or sperm may be used after recovery, when pregnancy or fertility treatment is considered medically appropriate by the oncology and fertility teams. 

Frequently Asked Questions (FAQ) 

Will fertility preservation delay my cancer treatment?
Often not. Egg freezing usually takes about 10–14 days, subject to your oncologist’s approval. 
Often, yes. Random-start stimulation can begin at different cycle stages when medically appropriate.
No. Future success depends mainly on age, cell quality and health after cancer treatment.